The data underlying the results presented in the study are freely accessible through the GUDMAP database at <https://doi.org/10.25548/16-WMM4>.

1. Introduction {#sec005}
===============

Men and dogs develop prostatic disorders spontaneously and in an aging- and androgen-dependent fashion. \[[@pone.0232564.ref001]--[@pone.0232564.ref011]\] Human and dog prostates organize into distinct anatomical zones with an externally bound fibromuscular capsule (anatomical features not shared by the mouse prostate). \[[@pone.0232564.ref012]\] Careful histological and molecular analyses of human prostate have revolutionized our understanding of the cell types of the prostate, revealing a gland that contains at least five epithelial cell types and three fibroblast-like stromal cell types that are organized into four zones. \[[@pone.0232564.ref013], [@pone.0232564.ref014]\] Canine prostate cell types and their spatial distribution across the gland have not been extensively examined using modern molecular and multiplex immunohistochemical methods. This void of knowledge hinders the translational potential of canine prostate findings to human medicine in a model species that bolsters great benefit to the prostate research field.

Our study utilizes young intact male dog prostate specimens to develop a regional atlas of prostatic epithelial and stromal cell types to enable future cross-species comparisons among dog, human and mouse models. We found that the dog prostate is anatomically divided into the capsule, peripheral, periurethral and urethral regions and that the distribution of prostatic epithelial and stromal cell types is not homogenous but distinct to each region. Next, we applied our new knowledge of canine prostate cell types and their spatial distribution and determined how the cellular source of procollagen 1A1 changes with age in intact male dogs.

Prostatism is a syndrome in aging males characterized by lower urinary tract symptoms (LUTS) that are responsive to medical and surgical therapies targeting the prostate.^1^ It was previously hypothesized that an enlarged prostate gland of non-neoplastic origin (benign prostatic hyperplasia, benign prostatic hypertrophy, and/or benign prostatic enlargement) was solely responsible for the syndrome.^2-5^ However, men with enlarged prostates can be asymptomatic and prostate size is weakly correlated with symptom severity.^6,7^ Recent studies show stronger correlations among prostatic inflammation (prostatitis), collagen accumulation (fibrosis), and LUTS severity. \[[@pone.0232564.ref008]--[@pone.0232564.ref016]\]

We previously used whole transverse sections of canine prostate to map aging- and castration-mediated changes in prostatic collagen architecture. \[[@pone.0232564.ref012]\] We found that aging increases collagen fiber thickness and density in the capsule and peripheral regions of intact dogs. \[[@pone.0232564.ref012]\] Numerous studies across multiple organ systems have identified myofibroblasts as fibrosis inducing cell types. \[[@pone.0232564.ref015]--[@pone.0232564.ref020]\] The second goal of this study is to test if myofibroblast populations expand and produce pro-collagen type 1A1 in the regions of the canine prostate prone to aging related collagen accumulation. We found that aging does not significantly alter the distribution of hematolymphoid cells (defined as cells immunopositive for protein tyrosine phosphatase receptor type C, also known as CD45), myofibroblasts (defined as cells immunopositive for vimentin (VIM), actin alpha 2 (ACTA2+) and S100 calcium binding protein A4 (S100A4, also known as fibroblast specific protein 1). Aging does not significantly change abundance of myofibroblasts, hematolymphoid or pro-collagen 1A1 positive cells. Instead, aging shifts the identity of procollagen 1A1 producing cells from predominantly ACTA2+, S100A4+ myofibroblasts to predominately ACTA2-, S100A4+ fibroblasts. Our results will help direct development of appropriate therapeutics for collagen accumulation in aged intact males.

2. Materials and methods {#sec006}
========================

2.1. Prostatic tissue collection, preparation, and processing {#sec007}
-------------------------------------------------------------

Canine prostatic tissue sources were previously described. \[[@pone.0232564.ref012]\] Prostates were collected postmortem from dogs euthanized for reasons other than prostatic disease. Prostates were from the Dane County Humane Society (Madison, WI), the University of Wisconsin-Madison Veterinary Teaching Hospital Necropsy Service (Madison, WI), Covance (Madison, WI), and the Mayo Clinic (Rochester, MN). Dogs ranged in age from 0.83 years to 15 years with a mean of 5.95 years and median of 5 years. They ranged in weight from 4.82 to 47.10 kg with a mean of 27.02 kg and median of 28.5 kg. Weight information was not recorded for six dogs at time of euthanasia. Prostates were obtained from multiple breeds to ensure representation across the canine population: Golden Retriever (4), Beagle (2), Border Collie (2), Pit Bull (2), Boxer (1), Cocker Spaniel (1), Doberman Pinscher (1), French Bulldog (1), Labrador Retriever (1), Miniature Poodle (1), Rat Terrier (1), Rottweiler (1), Shih Tzu (1), Standard Poodle (1), Weimaraner (1), mixed breed (8), and unknown breed (2).

Benign prostatic enlargement occurs in intact dogs but not neutered dogs and is most common in intact dogs \>6 years of age but may begin as early as 2.5 years of age. \[[@pone.0232564.ref001]\] Therefore, to maximize group size and comparisons between young and old, this study included young (≤3 years) and old (≥5 years) intact dogs and excluded middle aged dogs. Intact dogs were defined as those with two palpable testicles present in scrotum at the time of euthanasia. Dogs with unilateral or bilateral cryptorchidism were excluded.

Prostates were fixed and stored in neutral-buffered formalin. Prostates were bisected by a single dorsal-ventral cut at cranial-caudal midline and then cut into slices suitable for embedding. Central slices were oriented in transverse plane, embedded in paraffin, and sectioned by the University of Wisconsin-Madison Veterinary Teaching Hospital Histology Service. Twenty serial sections were taken from each embedded slice. The first and eleventh section were stained with hematoxylin and eosin, and the second and twelfth were stained with picrosirius red. All remaining slides were utilized for immunohistochemistry.

2.2. Immunohistochemistry {#sec008}
-------------------------

Immunofluorescence staining was conducted as previously described. \[[@pone.0232564.ref021]\] Briefly, tissue sections (5 μm) were deparaffinized with xylene and rehydrated in a series of graded ethanols (100%, 75%, 50%). Microwave decloaking was performed in 10 mM sodium citrate (pH 6.0) and non-specific sites were blocked in TBSTw containing 1% Blocking Reagent (Roche Diagnostics, Indianapolis, IN), 5% normal goat or donkey sera, 1% bovine serum albumin fraction 5. Primary and secondary antibodies are listed in [Table 1](#pone.0232564.t001){ref-type="table"}. Immunofluorescent staining was imaged using a BZ-X710 digital microscope (Keyence, Itasca, IL, USA) fitted with at 20x (PlanFluor, NA 0.45) objective. Some tissue sections were imaged using an Eclipse E600 compound microscope (Nikon Instruments Inc., Melville, NY) fitted with a 20x dry objective (Plan Fluor NA = 0.75; Nikon, Melville, NY) and equipped with NIS elements imaging software (Nikon Instruments Inc.). Fluorescence was detected using DAPI (2-(4-amidinophenyl)-1H -indole-6-carboxamidine), FITC, Texas Red (Chroma Technology Corp, Bellows Fall, VT), and CY5 filter cubes (Nikon, Melville, NY).
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###### Primary and secondary antibodies.

![](pone.0232564.t001){#pone.0232564.t001g}

  Name(s)                                           Symbol      Species      Antibody Registry (RRID)   Supplier                               Catalog Number                      Dilution   Un-masking   Fig \#
  ------------------------------------------------- ----------- ------------ -------------------------- -------------------------------------- ----------------------------------- ---------- ------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Actin alpha 2                                     ACTA2       Goat         AB 10980764                Thermo Fisher Sci.                     PA5-18292                           1:100      Citrate      [2](#pone.0232564.g002){ref-type="fig"}, [3](#pone.0232564.g003){ref-type="fig"}, [4](#pone.0232564.g004){ref-type="fig"}, [5](#pone.0232564.g005){ref-type="fig"}, [S2](#pone.0232564.s002){ref-type="supplementary-material"}
  Platelet and endothelial cell adhesion molecule   PECAM       Mouse        AB 2801330                 Santa Cruz Biotech.                    SC-376764                           1:200      Tris EDTA    [S2](#pone.0232564.s002){ref-type="supplementary-material"}
  Platelet derived growth factor receptor beta      PDGFRB      Rabbit       AB 2162497                 Cell Signaling Tech.                   3169S                               1:100      Tris EDTA    [S2](#pone.0232564.s002){ref-type="supplementary-material"}
  Keratin 5                                         KRT5        Chick        AB_2565054                 Biolegend                              905901                              1:100      Citrate      [1](#pone.0232564.g001){ref-type="fig"}
  Keratin 8/18                                      KRT8/18     Guinea Pig   AB 1284055                 Fitzgerald                             20R-CP004                           1:500      Citrate      [1](#pone.0232564.g001){ref-type="fig"}
  Chromogranin A                                    CHGA        Rabbit       AB 301704                  Abcam                                  ab15160                             1:200      Citrate      [1](#pone.0232564.g001){ref-type="fig"}
  Vimentin                                          VIM         Mouse        AB 445527                  Abcam                                  AB20346                             1:250      Citrate      [2](#pone.0232564.g002){ref-type="fig"}, [3](#pone.0232564.g003){ref-type="fig"}, [4](#pone.0232564.g004){ref-type="fig"}
  Protein tyrosine phosphatase, receptor type C     PTPRC       Rabbit       AB 442810                  Abcam                                  AB10558                             1:500      Citrate      [2](#pone.0232564.g002){ref-type="fig"}, [4](#pone.0232564.g004){ref-type="fig"}, [S3](#pone.0232564.s003){ref-type="supplementary-material"}, [S4](#pone.0232564.s004){ref-type="supplementary-material"}
  S100 calcium binding protein A4                   S100A4      Rabbit       AB_2183775                 Abcam                                  AB27957                             1:200      Citrate      [3](#pone.0232564.g003){ref-type="fig"}, [4](#pone.0232564.g004){ref-type="fig"}, [5](#pone.0232564.g005){ref-type="fig"}
  Procollagen type I                                ProCOL1A1   Mouse        N/A                        Developmental Studies Hybridoma Bank   SP1.D8-c (concentrated, 238ug/mL)   1:1000     Citrate      [5](#pone.0232564.g005){ref-type="fig"}
  Anti-mouse Alexa Fluor 647                        \-          Donkey       AB_2340846                 Jackson Immuno Res.                    715-545-150                         1:250      \-           [2](#pone.0232564.g002){ref-type="fig"}, [3](#pone.0232564.g003){ref-type="fig"}, [4](#pone.0232564.g004){ref-type="fig"}, [5](#pone.0232564.g005){ref-type="fig"}, [S2](#pone.0232564.s002){ref-type="supplementary-material"}
  Anti-goat Alexa Fluor RRX                         \-          Donkey       AB_2340423                 Jackson Immuno Res.                    705-295-147                         1:250      \-           [2](#pone.0232564.g002){ref-type="fig"}, [3](#pone.0232564.g003){ref-type="fig"}, [4](#pone.0232564.g004){ref-type="fig"}, [S2](#pone.0232564.s002){ref-type="supplementary-material"}
  Anti-rabbit Alexa Fluor 488                       \-          Donkey       AB 2313584                 Jackson Immuno Res.                    711-545-152                         1:250      \-           [1](#pone.0232564.g001){ref-type="fig"}, [2](#pone.0232564.g002){ref-type="fig"}, [3](#pone.0232564.g003){ref-type="fig"}, [4](#pone.0232564.g004){ref-type="fig"}, [S2](#pone.0232564.s002){ref-type="supplementary-material"}, [S3](#pone.0232564.s003){ref-type="supplementary-material"}
  Anti- chicken Alexa Fluor 594                     \-          Donkey       AB_2340377                 Jackson Immuno Res.                    703-585-155                         1:250      \-           [1](#pone.0232564.g001){ref-type="fig"}
  Anti- guinea pig Alexa Fluor 647                  \-          Goat         AB_2337446                 Jackson Immuno Res.                    106-605-003                         1:250      \-           [1](#pone.0232564.g001){ref-type="fig"}
  Anti-goat Alexa Fluor 488                         \-          Donkey       AB_2340428                 Jackson Immuno Res.                    705-545-003                         1:250      \-           [5](#pone.0232564.g005){ref-type="fig"}
  Anti-rabbit Alexa Fluor 546                       \-          Donkey       AB_2534016                 Thermo Fisher Scientific               A10040                              1:250      \-           [5](#pone.0232564.g005){ref-type="fig"}
  Anti-rabbit Alexa Fluor RRX                       \-          Donkey       AB_2340613                 Jackson Immuno Res.                    711-295-152                         1:250      \-           [S4](#pone.0232564.s004){ref-type="supplementary-material"}

2.3. Cell counting {#sec009}
------------------

Two to three randomly selected images were analyzed per region per dog. The capsule is defined as the outer layer of fibromuscular tissue encapsulating the prostate ([S1 Fig](#pone.0232564.s001){ref-type="supplementary-material"}). The urethral region contains urethral luminal cells as well as their supporting stroma ([S1 Fig](#pone.0232564.s001){ref-type="supplementary-material"}). The peripheral and periurethral regions are not delineated by a visible anatomic or histologic boundaries. We defined them by dividing the glandular region into two concentric rings of equal thickness ([S1 Fig](#pone.0232564.s001){ref-type="supplementary-material"}). Absolute cell counts (all cells containing a nuclei and meeting staining criteria for the cell type) were performed manually using Image J cell counter. \[[@pone.0232564.ref022]\] All cells were counted in every image (one image = one 20X field; the size of the 20X field for samples imaged using the Nikon microscope is 435.84 μm X 331.42 μm, the 20X field size for the BZ-X710 microscope is 964.19 μm X 723.14 μm). Antibodies against cytokeratin 8/18 (KRT 8/18), cytokeratin 5 (KRT 5), and chromogranin A (CHGA) were used to identify luminal \[[@pone.0232564.ref021], [@pone.0232564.ref023]\] (KRT 8/18+, KRT 5-, CHGA-), intermediate \[[@pone.0232564.ref021], [@pone.0232564.ref023]\] (KRT 8/18+, KRT 5+, CHGA-), and basal \[[@pone.0232564.ref021], [@pone.0232564.ref023]\] (KRT 8/18-, KRT 5-, CHGA-) epithelial cells. Neuroendocrine cells \[[@pone.0232564.ref021], [@pone.0232564.ref024], [@pone.0232564.ref025]\] (KRT 8/18-, KRT 5-, CHGA+) were also identified with this stain combination. Antibodies against smooth muscle actin (ACTA2), protein tyrosine phosphatase receptor type C (PTPRC, also known as CD45), and vimentin (VIM) were used to identify fibrocytes \[[@pone.0232564.ref021], [@pone.0232564.ref026]--[@pone.0232564.ref030]\] (ACTA2+, PTPRC+, VIM+), and other hematolymphoid cells (PTPRC+, not a fibrocyte). Antibodies against ACTA2, VIM, and fibroblast specific protein (S100A4, also known as FSP1) were used to identify myofibroblasts \[[@pone.0232564.ref021], [@pone.0232564.ref031]--[@pone.0232564.ref034]\] (ACTA2+, VIM+, S100A4+), and fibroblasts \[[@pone.0232564.ref021], [@pone.0232564.ref027], [@pone.0232564.ref035]--[@pone.0232564.ref037]\] (ACTA2-, VIM+, S100A4+). Results are expressed as cells per mm^2^. Statistical comparisons were made between or among images collected form the same microscope using the same imaging settings and magnification.

2.4. Determining distribution of hematolymphoid cells from the urethra to the capsule {#sec010}
-------------------------------------------------------------------------------------

Immunohistochemistry, as described in section 2.2, was performed to label hematolymphoid cells using antibodies against protein tyrosine phosphatase receptor type C (PTPRC) and imaged with the BZ-X710 digital microscope (Keyence, Itasca, IL, USA) fitted with the 20x (PlanFluor, NA 0.45) objective. From transverse sections, we collected 20X image tiles and stitched them to produce a continuous image running from capsule to urethra ([S4 Fig](#pone.0232564.s004){ref-type="supplementary-material"}). The stitched image was rotated so that the urethra was oriented on the left side. The image was opened in image J, the entire image was selected and the tool 'Plot Profile' applied to determine the average gray value for each column of pixels in the image. Gray values were exported as (X,Y) coordinates and used to create a linear plot of inflammatory cell distribution. Images containing PTPRC staining were overlaid with those containing DAPI and the x-axis of the linear plot of gray values was fit to the x-axis of the new overlay image ([S4A--S4D Fig](#pone.0232564.s004){ref-type="supplementary-material"}). Areas with more hematolymphoid cells have higher gray values, areas with less hematolymphoid cells have lower gray values.

2.5. Statistical analyses {#sec011}
-------------------------

Statistical analyses were performed with Graph Pad Prism 8.0.2 (Graphpad Software, La Jolla, California). The Shapiro-Wilk test was used to test for normality and transformation was applied to normalize data if necessary. The F-test was used to test for homogeneity of variance for pairwise comparisons. Welch's correction was applied when variances were unequal. When variances were equal, Student's t-test was used to test for differences between groups. The Mann Whitney test was applied when data could not be normalized through transformation. One-way analysis of variance (ANOVA) followed by Tukey's post-hoc analysis was used for identifying differences among groups. A p value of less than 0.05 was considered statistically significant.

3. Results {#sec012}
==========

3.1. Distribution of prostatic cell types in the young intact dog {#sec013}
-----------------------------------------------------------------

Historical accounts of canine prostate histology describe an unequal distribution of epithelial and stromal cells, with stromal cells predominating close to the urethra and epithelial cells predominating peripherally. \[[@pone.0232564.ref038]\] However, modern descriptions have lost this distinction and describe a histologically homogenous gland. \[[@pone.0232564.ref005], [@pone.0232564.ref039]\] We previously published an immunohistochemical key for identifying and objectively quantifying mouse prostatic epithelial, perivascular, and fibromuscular cells. \[[@pone.0232564.ref021]\] We apply an adapted immunohistochemical key here to test whether dog prostate cell types are homogenously distributed across the gland. The only differences between the prostate cell identification key previously published for mouse \[[@pone.0232564.ref021]\] and the key applied here for dog are that 1) the mouse key identified two unique populations of 'Other hematolymphoid cells' differentiated by vimentin immunostaining and the dog key combines both populations into a single, 'Other hematolymphoid cell' population, 2) the dog prostate cell identification key excludes an androgen receptor stain because the antibody used previously for mice does not cross react with dog, and 3) Chromogranin A was used in place of synaptophysin to identify neuroendocrine cells. We used epithelial and fibromuscular stains to determine the regional distribution of four epithelial cell types and four stromal cell types in young intact male dog prostate. We also successfully detect endothelial cells, pericytes, and perivascular smooth muscle myocytes as shown in [S2 Fig](#pone.0232564.s002){ref-type="supplementary-material"}.

### 3.1.1. Epithelial cells {#sec014}

Antibodies against cytokeratin 8/18 (KRT 8/18), cytokeratin 5 (KRT 5), and chromogranin A (CHGA) are used to identify luminal \[[@pone.0232564.ref021], [@pone.0232564.ref023]\] (KRT 8/18+, KRT 5-, CHGA-, [Fig 1B](#pone.0232564.g001){ref-type="fig"}), intermediate \[[@pone.0232564.ref021], [@pone.0232564.ref023]\] (KRT 8/18+, KRT 5+, CHGA-, [Fig 1C](#pone.0232564.g001){ref-type="fig"}), and basal \[[@pone.0232564.ref021], [@pone.0232564.ref023]\] (KRT 8/18-, KRT 5-, CHGA-, [Fig 1D](#pone.0232564.g001){ref-type="fig"}) epithelial cells. Neuroendocrine cells \[[@pone.0232564.ref021], [@pone.0232564.ref024], [@pone.0232564.ref025]\] (KRT 8/18-, KRT 5-, CHGA+, [Fig 1E](#pone.0232564.g001){ref-type="fig"}) are also identified. Epithelial cells in general and neuroendocrine cells in particular are not detected in the capsule ([Fig 1F](#pone.0232564.g001){ref-type="fig"}) but are present in the peripheral region ([Fig 1G](#pone.0232564.g001){ref-type="fig"}), the periurethral region ([Fig 1H](#pone.0232564.g001){ref-type="fig"}) and the prostatic urethra ([Fig 1I](#pone.0232564.g001){ref-type="fig"}). The peripheral region consists of 96% epithelial cells, the periurethral region consists of 67% epithelial cells and the prostatic urethra consists of 33% epithelial cells ([Fig 1H](#pone.0232564.g001){ref-type="fig"}). Luminal epithelial cells are absent from the capsule, comprise 100% of epithelial cells in the peripheral region, 96% of epithelial cells in the periurethral region and 67% of epithelial cells in the urethral region ([Fig 1I](#pone.0232564.g001){ref-type="fig"}). Basal and intermediate epithelial cells are not detected in the capsule, comprise \<1% of epithelial cells in the peripheral region, 4% of epithelial cells in the periurethral region, and 31% of epithelial cells in the urethral region ([Fig 1I](#pone.0232564.g001){ref-type="fig"}). Neuroendocrine cells are not detected in the capsule, comprise \<1% of epithelial cells in peripheral and perirurethral regions, and comprise 2% of epithelial cells in the urethral region ([Fig 1I](#pone.0232564.g001){ref-type="fig"}).

![Young intact canine prostatic epithelial cell composition and distribution.\
Multiplex immunostaining with antibodies against Keratin 5 (KRT5), Keratin 8/18 (KRT8/18) and Chromogranin A (CHGA) was performed on complete transverse sections of young (≤3 years old) intact male canine prostate. Nuclei were stained with DAPI. (A) The prostate was divided into capsule, peripheral, periurethral and urethral zones to describe the regional distribution of cells. B-E depict the staining pattern criteria of each quantified cell type with an example cell image. Basal epithelial, intermediate epithelial, luminal epithelial and neuroendocrine cells were identified by multiplex staining. (F-I) Epithelial cells were visualized and densities quantified as a function of (J) all cells and (K) distribution of epithelial cell types within each region. (J) Results are mean ± SE, A one-way ANOVA was used to compare regions, Letters (a-d) indicate that epithelial cell density significantly differs (p\<0.05) across regions. Differences between each examined prostatic region and (a) capsule, (b) peripheral, (c) periurethral, (d) urethral regions are identified. (K) Results are mean (%) of total epithelial cells. Images are representative of three young intact male dog prostates. High resolution images contributing to this figure are freely accessible through the GUDMAP database at <https://doi.org/10.25548/16-WMM4>.](pone.0232564.g001){#pone.0232564.g001}

### 3.1.2. Stromal cells {#sec015}

ACTA2, protein tyrosine phosphatase receptor type C (PTPRC), and vimentin (VIM) are used to identify fibrocytes \[[@pone.0232564.ref021], [@pone.0232564.ref026]--[@pone.0232564.ref030]\] (ACTA2+, PTPRC+, VIM+, [Fig 2B](#pone.0232564.g002){ref-type="fig"}), and other hematolymphoid cells (PTPRC+, not a fibrocyte, [Fig 2C](#pone.0232564.g002){ref-type="fig"}) in canine prostates. Fibrocytes are relatively rare but comparable in frequency across all regions of the prostate ([Fig 2D--2G and 2H](#pone.0232564.g002){ref-type="fig"}). The density of 'Other hematolymphoid cells' does not significantly differ across prostatic regions ([Fig 2D--2G and 2I](#pone.0232564.g002){ref-type="fig"}).

![Young intact canine prostate fibrocyte and other hematolymphoid cell distributions.\
Multiplex immunostaining with antibodies against smooth muscle actin (ACTA2), protein tyrosine phosphatase, receptor type C (PTPRC) and vimentin (VIM) was performed on (A) complete transverse sections of young (≤3 years old) intact male canines. Nuclei were stained with DAPI. B-C depict the staining pattern criteria of each quantified cell type with an example cell image. Fibrocytes and other hematolymphoid cells were identified by multiplex staining. (D-I) Fibrocytes and Other hematolymphoid cells were visualized and densities quantified within each region. (H-I) Results are mean ± SE. A one-way ANOVA was used to compare cell densities among regions. There was no significant difference (p\<0.05) among groups. Images are representative of 6--8 young intact male dog prostates. High resolution images shown here and others from biological replicates are available through the GUDMAP database at <https://doi.org/10.25548/16-WMM4>.](pone.0232564.g002){#pone.0232564.g002}

ACTA2, VIM, and fibroblast specific protein (S100A4) are used to identify myofibroblasts \[[@pone.0232564.ref021], [@pone.0232564.ref031]--[@pone.0232564.ref034]\] (ACTA2+, VIM+, S100A4+, [Fig 3B](#pone.0232564.g003){ref-type="fig"}), and fibroblasts \[[@pone.0232564.ref021], [@pone.0232564.ref027], [@pone.0232564.ref035]--[@pone.0232564.ref037]\] (ACTA2-, VIM+, S100A4+, [Fig 3C](#pone.0232564.g003){ref-type="fig"}) in canine prostates. Fibroblasts are more abundant in the urethra than in the peripheral region and myofibroblasts are less abundant in the peripheral and periurethral than the urethra.

![Young intact canine prostatic myofibroblast and fibroblast distributions.\
Multiplex immunostaining with antibodies against smooth muscle actin (ACTA2), fibroblast specific protein (S100A4) and vimentin (VIM) was performed on (A) complete transverse sections of young (≤3 years old) intact male canines. Nuclei were stained with DAPI. B-C depict the staining pattern criteria of each quantified cell type with an example cell image. Fibroblasts and myofibroblasts were identified based by multiplex staining. (D-I) Fibroblasts and myofibroblasts were visualized and densities quantified within each region. (H-I) Results are mean ± SE. A one-way ANOVA was used to compare cell densities among regions. Cell density differences between regions (p \<0.05) are depicted on graphs. Images are representative of four young intact male dog prostates. High resolution images shown here and others from biological replicates are available through the GUDMAP database at <https://doi.org/10.25548/16-WMM4>.](pone.0232564.g003){#pone.0232564.g003}

3.2. Aging does not change the density of myofibroblasts, fibroblasts, and hematolymphoid cells in the capsule and peripheral region of intact male dogs {#sec016}
--------------------------------------------------------------------------------------------------------------------------------------------------------

We previously identified an aging- and androgen-dependent increase in prostatic collagen density in the prostatic capsule and peripheral regions of intact male canines. \[[@pone.0232564.ref012]\] We also compared tissue architecture between young and old intact male dogs across the four prostatic regions ([S3 Fig](#pone.0232564.s003){ref-type="supplementary-material"}). Here we test the hypothesis that aging increases myofibroblast density in these canine prostate regions.

We stained prostate sections from old intact male dogs and counted myofibroblasts \[[@pone.0232564.ref021], [@pone.0232564.ref031]--[@pone.0232564.ref034]\] and fibroblasts \[[@pone.0232564.ref021], [@pone.0232564.ref027], [@pone.0232564.ref035]--[@pone.0232564.ref037]\] in each region. The number myofibroblasts and fibroblast per 20X field in the capsule and peripheral region did not significantly differ between old and young intact males ([Fig 4](#pone.0232564.g004){ref-type="fig"}).

![Aging does not change myofibroblast, fibroblast, and hematolymphoid cell densities in the intact male dog prostate.\
Multiplex immunostaining with antibodies against protein tyrosine phosphatase, receptor type C (PTPRC), smooth muscle actin (ACTA2), fibroblast specific protein (S100A4) and vimentin (VIM) was performed on complete transverse sections of young (≤3 years old) and old (≥5 years old) intact male canine prostates. Nuclei were stained with DAPI. Densities of (A-D) hematolymphoid cells (PTPRC+), (E-H) fibroblasts (S100A4+, ACTA2-, VIM+) and (I-L) myofibroblasts (S100A4+, ACTA2+, VIM+) were determined for the capsule, peripheral, periurethral, and urethral regions. Results are mean ± SE, five to eight young males and three to four old males per group. Student's t-test was used to compare cell densities between young and old intact males. Cell densities did not significantly differ (p\<0.05) between young and old males in any of the prostatic regions examined. P-values between 0.1 and 0.05 are listed. High resolution images shown here and others from biological replicates are available through the GUDMAP database at <https://doi.org/10.25548/16-WMM4>.](pone.0232564.g004){#pone.0232564.g004}

Collagen accumulation is often linked to inflammation. \[[@pone.0232564.ref040]\] We examined the frequency of hematolymphoid cells within each prostatic region and the continuous distribution across the proximodistal axis of young intact male prostate ([S4](#pone.0232564.s004){ref-type="supplementary-material"} and [S5](#pone.0232564.s005){ref-type="supplementary-material"} Figs). We found that hematolymphoid cells are not distributed in a regional or proximodistal pattern but rather distributed homogenously throughout the prostate.

We tested whether aging increases the number of hematolymphoid cells in the peripheral and capsule regions of old versus young intact males. We stained sections of prostate from old intact male dogs and performed regional counts of hematolymphoid cells (PTPRC+). The number of hematolymphoid cells in the prostatic capsule and peripheral regions does not significantly differ between old and young intact males ([Fig 4](#pone.0232564.g004){ref-type="fig"}).

3.3. Aging shifts the predominant prostatic procollagen 1A1 producing cells from myofibroblasts to fibroblasts {#sec017}
--------------------------------------------------------------------------------------------------------------

We stained sections from young and old intact male dogs with procollagen 1A1 (ProCOL1A1), smooth muscle actin (ACTA2), and fibroblast specific protein (S100A4) to identify collagen synthesizing cells. The overall frequency of ProCOL1A1+ cells in the prostatic capsule and peripheral regions does not significantly differ between young and old intact males ([Fig 5A--5D](#pone.0232564.g005){ref-type="fig"}). There is, however, an aging-related shift in the identity of procollagen 1A1 producing cells. Procollagen 1A1 producing S100A4+, ACTA2+ cells (prostatic myofibroblasts) are more abundant in young dogs, while procollagen 1A1 producing S100A4+, ACTA2- (prostatic fibroblasts) are more abundant in old dogs ([Fig 5E--5H](#pone.0232564.g005){ref-type="fig"}).

![Aging shifts prostatic procollagen 1A1 production in intact male dog prostate from myofibroblasts to fibroblasts.\
Multiplex immunostaining with antibodies against procollagen 1A1 (ProCol 1A1), smooth muscle actin (ACTA2), and fibroblast specific protein (S100A4) was performed on complete transverse sections of young (≤3 years old) and old (≥5 years old) intact male canine prostate. Nuclei were stained with DAPI. (A-D) The overall density of ProCol 1A1+ cells was determined in the capsule, peripheral, periurethral, and urethral regions. (E-H) Cell identities of prostatic ProCol 1A1+ cell types were determined in the capsule, peripheral, periurethral, and urethral regions. Results are mean ± SE, five young males and four old males per group. Student's t-test was used to compare overall ProCol 1A1+ cell density and density of specific ProCol1A1+ cell types between young and old. A single asterisk identifies a p-value between 0.01 and 0.05 and a double asterisk identifies a p-value less than 0.01. High resolution images shown here and others from biological replicates are available through the GUDMAP database at <https://doi.org/10.25548/16-WMM4>.](pone.0232564.g005){#pone.0232564.g005}

4. Discussion {#sec018}
=============

We adapted an immunohistochemical prostate cell identification key, previously published for use in mice, \[[@pone.0232564.ref021]\] for use in dogs. We successfully stained dog prostate sections with the same antibodies and same antibody combinations previously used to identify mouse prostatic cell types, enabling future comparisons between these two model species. We also determined the abundance and distribution of individual cell types to enable comparisons to human prostate \[[@pone.0232564.ref013], [@pone.0232564.ref014]\] and address whether canine prostate has a homogeneous \[[@pone.0232564.ref005], [@pone.0232564.ref039]\] or heterogenous \[[@pone.0232564.ref038]\] composition. Our activities establish a baseline cellular map of the canine prostate that will be used to determine the impact of age, inflammation and other disease processes on prostatic cellular composition and to ultimately identify disease causing cell types. Our results indicate that canine prostate cell composition is heterogeneous, consistent with older descriptions of the canine prostate in which epithelial cells predominate in the peripheral region and stromal cells predominate in the periurethral region. \[[@pone.0232564.ref038]\] The peripheral and periurethral regions are not delineated by a visible anatomic or histologic boundary. We defined them by dividing the glandular region into two concentric rings of equal thickness. Our approach led to the discovery that the peripheral and periurethral regions differ in epithelial and stromal cell composition (Figs [1](#pone.0232564.g001){ref-type="fig"} and [3](#pone.0232564.g003){ref-type="fig"}) and propensity to develop aging-related collagen accumulation \[[@pone.0232564.ref012]\]. Our results support the notion that peripheral and periurethral region microenvironments uniquely regulate cell behavior and cell composition and may even confer differences in aging-related pathology, much as the human prostate transition and peripheral zones differ in susceptibility to benign hyperplasia and cancer. \[[@pone.0232564.ref041]\]

We show here that canine prostate epithelial cells are not equally distributed between prostatic zones and specifically that basal cells are more frequent in the canine prostatic urethra. Epithelial cell distribution has not been quantified in the mouse prostate, but published images and anecdotal observations hint towards increased basal cells in the mouse prostatic urethra. \[[@pone.0232564.ref021]\] Henry et. Al. recently showed enriched epithelial cells in the peripheral zone of human prostate compared to transition/central zones in fluorescence-activated cell sorting. They also include whole transverse sections of human prostate stained for KRT5 and KRT8 with more visually prominent KRT5 staining in the urethra. \[[@pone.0232564.ref013]\]

Activated myofibroblasts mediate fibrosis in many organ systems. \[[@pone.0232564.ref015]--[@pone.0232564.ref020]\] Even though we noted previously that aging causes collagens to accumulate in the capsule and peripheral regions of intact canine prostate, \[[@pone.0232564.ref012]\] we found no evidence that aging causes myofibroblasts to become more frequent or initiate pro-collagen 1A1 synthesis in these prostatic regions. Instead, aging shifted the most dominant procollagen 1A1 positive stromal cell type from prostatic myofibroblasts to fibroblasts. Because prostatic collagens accumulate with age, and because we did not observe a net increase in overall quantity of prostatic collagen producing cells, we consider the aging-related transition in the identity of collagen producing cells to be of probable significance with respect to prostatic collagen homeostasis. It is possible that the procollagen 1A1 producing fibroblasts in the older male prostate are more efficient at synthesizing collagens than procollagen 1A1 producing myofibroblasts in young dogs and therefore drive pathological collagen accumulation. We will explore this hypothesis in future studies.

The identity of collagen producing cells has clinical significance with respect to pharmacological targeting of collagen biosynthesis pathways within the aging prostate. We therefore considered two possible mechanisms by which aging could drive a change in collagen producing cell identities. First, it is possible the procollagen 1A1 producing fibroblasts represent a unique but rare cell lineage in young intact male prostate and is driven by the aging process to proliferate and become more numerous. A second possibility is that procollagen 1A1 positive prostatic fibroblasts in older intact males derive from smooth muscle actin positive myofibroblasts and undergo an aging dependent loss of smooth muscle actin expression. Our results favor the second possibility, as we did not observe a corresponding loss of myofibroblasts with age. Prospective studies are needed to determine order of events and causal relationships.

It is important to note that we used a small but diverse sampling of dog prostates to collect baseline information of the canine prostate that is generalizable to the intact male canine population as a whole. We did not obtain sufficient numbers to stratify our population by factors such as breed, body mass, or prostate volume, however this is an important future direction. Future studies are needed to understand the intersection of inflammation, collagen accumulation, and other factors contributing to prostatism including body mass, prostate volume, and breed in dogs and race in humans.

5. Conclusions {#sec019}
==============

Our results concur with older studies of dog prostate documenting a heterogeneous rather than homogenous histologic structure across the capsule, peripheral, periurethral and urethral regions. Our results also suggest that prostatic myofibroblasts, unlike myofibroblast in other tissues, do not expand with age and do not increase collagen production with age in intact male dogs. Finally, we identified aging-related shift in cell types responsible for collagen production that could play an important role in collagen accumulation and urinary dysfunction in aging males. All images from this project are available in the GUDMAP database at <https://doi.org/10.25548/16-WMM4>.

Supporting information {#sec020}
======================

###### Prostatic regions in canine prostate.

Shown is a tile scan of a hematoxylin and eosin stained prostate of a young intact male dog overlaid with regions (left) and shown in the same scale (right). The urethral region is defined by the urethral epithelium and its associated stroma (circumferential orientation of stromal fibers). The capsule is the stroma including large vessels and large bundles of muscle comprising the outer boundary of the prostate and is void of epithelial cells. The periurethral and peripheral regions do not have clear anatomical boundaries and are defined by dividing the tissue between the capsule and urethra into two rings. This particular prostate is a rare example of a (\*) thin band of stroma running circumferentially and separating the two zones in the dorsal portion of the gland). High resolution images shown here and others from biological replicates are available through the GUDMAP database at <https://doi.org/10.25548/16-WMM4>.

(TIF)

###### 

Click here for additional data file.

###### Perivascular cells in young intact canine prostate.

Multiplex immunostaining with antibodies against smooth muscle actin (ACTA2), Platelet derived growth factor receptor beta (PDGFRB) and Platelet and endothelial cell adhesion molecule (PECAM) was performed on complete transverse sections of the young (≤3 years old) intact male canines. Nuclei were stained with DAPI. (A-C) Endothelial cells, pericytes, and perivascular smooth muscle cells were identified based on combinatorial staining. Endothelial cells, pericytes, and perivascular smooth muscle cells were visualized within each region (capsule depicted in D). Images are representative of 9 young intact male dog prostates. High resolution images shown here and others from biological replicates are available through the GUDMAP database at <https://doi.org/10.25548/16-WMM4>.

(TIF)

###### 

Click here for additional data file.

###### Tissue architecture in young vs old dogs.

Sections from young and old intact male dogs were stained with hematoxylin and eosin. Results are representative of 9 young and 4 old intact male dog prostates. High resolution images shown here and others from biological replicates are available through the GUDMAP database at <https://doi.org/10.25548/16-WMM4>.

(TIF)

###### 

Click here for additional data file.

###### Hematolymphoid cell density is not altered by region.

Sections from young intact male dogs were immunostained with an antibody against protein tyrosine phosphatase, receptor type C (PTPRC). Nuclei were stained with DAPI. Hematolymphoid cells (PTPRC+) were visualized, and densities quantified within each region. Results are mean ± SE of 6--8 young intact male dog prostates, a one-way ANOVA was used to compare regions, no statistical differences were found between regions. High resolution images shown here and others from biological replicates are available through the GUDMAP database at <https://doi.org/10.25548/16-WMM4>.

(TIF)

###### 

Click here for additional data file.

###### Proximal to distal distribution of hematolymphoid cells.

Four prostates from young intact males were tile scanned in three 20X field tall strip from the urethra to the capsule in the right or left lateral portion of the gland (A-D). We used image J- plot profile to determine the average gray value for each column of pixels, creating a plot of the urethral to capsule distribution of hematolymphoid cells in the prostate (A-D). Using this technique, we found that hematolymphoid cells were not distributed in a proximal to distal pattern but rather distributed fairly ubiquitously throughout the prostate. High resolution images shown here and others from biological replicates are available through the GUDMAP database at <https://doi.org/10.25548/16-WMM4>.

(TIF)

###### 

Click here for additional data file.

10.1371/journal.pone.0232564.r001
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An immunohistochemical prostate cell identification key indicates that aging shifts procollagen 1A1 production from myofibroblasts to fibroblasts in dogs prone to prostate-related urinary dysfunction

PLOS ONE

Dear Dr. Vazina:

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

**Reviewer \#1:**

The authors present interesting data that show a shift in the collagen-producing cells of the prostate in dogs, from a myofibroblastic cell type to a mature fibroblastic cell type. The results are important because, if confirmed, this information can be used to understand how fibrosis in aging prostates in a dog may be useful in our understanding of this important pathological phenomenon in humans. The findings are also important because previous assumptions within the field were that there was a cell type shift behind changes in collagen deposition in the prostate; the findings of this paper suggest that it is not a cell type shift in numbers, but rather a shift in which cells produce the collagen. Therefore the findings of this paper may represent a shift in the paradigm on how we think of fibrosis and collagen deposition in the stromal compartment of the prostate. We look forward to future papers in this area building upon this information.

Minor comments for the authors to consider in the revision of this manuscript:

1\. the IHC figures should include higher power images in addition to the broader versions shown in the figures. It is appreciated that the lower power views allow a broad view, but additions of higher power images will greatly assist the readers\' abilities to see how the cell types are arranged with respect to each other. They will give a good view of architectural changes. In addition, H&E images should be included for this same purpose, and to reveal any possible developing pathologies from these collagen changes.

2\. For the data presented in Figures 3 (panels H and I), figure 4, and Figure 5 (Panels A through D), would it be a better representation to show these data as a percent of total cells rather than per image? There is a very large variability in some of these data, and perhaps an adjustment to the number of total cells might allow for reducing this across groups, and perhaps finding differences where p values currently outside the normally-accepted level of \"difference\" could be reduced to difference. IN addition, this would actually be a more valid way to assess the figures anyway.

3\. The authors could comment on the body mass of these dogs: is there any difference in obesity rates or other obvious BPH-related risk factors in some of the older animals that could play a role in collagen deposition and cell type shifts as the animals age? The group has a great resource of animals that could yield this information. If the numbers are too low currently to warrant further stratification, perhaps a comment on this would be warranted.

[**Reviewer \#2:**]{.ul}

The work by Ruetten *et al*looks at the identification of stromal cells responsible for the production of procollagen 1A1 in dogs with lower urinary tract dysfunction related to prostate changes associated with aging. The authors used immunohistochemical analysis to identify the location of these cells. This study provides a framework for future studies when looking at changes in prostatic diseases in dogs. However, there are a few questions that require clarification.

• Our current understanding of the human prostate anatomy is based on the classic work by McNeal (1968) who proposed four different prostatic zones based on their anatomic location and histological features. The presence of these four zones have been validated recently by others (Selman et al 2011, Samson 2012) and also using MRI technologies (Yacoub 2018). Please revised the statement "...that are organized into three zones" (lane 71) accordingly.

• Please revise the following statement for accuracy: "We found that aging increases collagen fiber thickness and density in the capsule and peripheral regions intact dogs susceptible to prostatism". The conclusions of this reference suggest that older dogs have increased collagen fiber thickness and density compared to young male dogs. However, in this particular paper there was not any evidence that these changes in collagen were present in dogs with "prostatism". Dogs were euthanized for reasons other than prostatic disease. Unlike humans, typically no clinical signs of LUTS are present in dogs unless the BPH condition progress to hematuria, tenesmus, urethral discharge or stilted gait. Similarly, in prostate cancer signs and symptoms are also present later in the disease.

• In figure 1 the data on epithelial cells is presented as a percentage over total number of cells, however from figure 2, number of cells/image. Given that each field is representative of the gland architecture, perhaps it will be more informative if the data is presented as percentage of total number of cells, also for consistency.

• Did the authors compared whether cell densities for each of these populations are different between the four regions? Looking at Figure 4 , it looks like there are more fibroblasts in the capsule and peripheral zone compared to the periurethral and urethral zones. Unfortunately, it is hard to determine because the y axis used are different between groups.

• Figure 5 (panels E to H) will benefit with the use of colors instead of the shades of gray. Another alternative is to use a combination of white, gray and black.

• The authors did a great job looking at epithelial and fibroblasts cell populations using a combination of markers to classify them (luminal/intermediate/basal and NE for epithelial cells and fibroblasts/myofibroblasts) and only use one marker for the hematolymphoid (?), perhaps one of the most well studied and diverse in terms of subpopulations. This study will be complete if the authors can provide some evidence of lymphoid and/or myeloid cell populations distribution across the dog prostate. Given that inflammatory processes are clearly involved in the promotion of collagen deposition (per the authors premise for looking at collagen in this study), determining whether macrophages or lymphocytes associate with areas of high collagen content or presence of specific fibroblasts population will give a much better picture on hematolymphoid cells in young vs old dogs.

• It is well known that larger breeds of dogs are at higher risk of developing prostate cancer. Did the authors compared whether changes in collagen deposition are different between different breeds?. Or if prostate size was associated with the composition/distribution of collagen?

==============================

Please submit your revised manuscript by Jul 19 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <plosone@plos.org>. When you\'re ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled \'Manuscript\'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

We look forward to receiving your revised manuscript.

Kind regards,

Mohammad Saleem., Academic Editor

PLOS ONE

Masonic Cancer Center, University of Minnesota

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and

<https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

10.1371/journal.pone.0232564.r002
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Response to reviewer comments for "An immunohistochemical prostate cell identification key indicates that aging shifts procollagen 1A1 production from myofibroblasts to fibroblasts in dogs prone to prostate-related urinary dysfunction".

Reviewer \#1:

The authors present interesting data that show a shift in the collagen-producing cells of the prostate in dogs, from a myofibroblastic cell type to a mature fibroblastic cell type. The results are important because, if confirmed, this information can be used to understand how fibrosis in aging prostates in a dog may be useful in our understanding of this important pathological phenomenon in humans. The findings are also important because previous assumptions within the field were that there was a cell type shift behind changes in collagen deposition in the prostate; the findings of this paper suggest that it is not a cell type shift in numbers, but rather a shift in which cells produce the collagen. Therefore, the findings of this paper may represent a shift in the paradigm on how we think of fibrosis and collagen deposition in the stromal compartment of the prostate. We look forward to future papers in this area building upon this information.

Comment 1: The IHC figures should include higher power images in addition to the broader versions shown in the figures. It is appreciated that the lower power views allow a broad view, but additions of higher power images will greatly assist the readers\' abilities to see how the cell types are arranged with respect to each other. They will give a good view of architectural changes. In addition, H&E images should be included for this same purpose, and to reveal any possible developing pathologies from these collagen changes.

Response: High power inlays have been added to Figures 1, 2, and 3. High resolution images contributing to the figures have been made freely accessible through the GUDMAP database. A supplemental figure has been added containing representative H&E images of old vs young intact dogs in all regions. Additional H&E images of all regions for all dog prostates used in this and our previous study have been made freely accessible through the GUDMAP database. A clickable digital object identifier is included in the text to direct readers to the GUDMAP database, where a library of images corresponding to this manuscript are stored. Note that the GUDMAP database contains all of the original data used for the figures -- not just the representative images that are shown, but all other data used to draw the conclusions. We include all raw data to enhance rigor and transparency.

Comment 2: For the data presented in Figures 3 (panels H and I), figure 4, and Figure 5 (Panels A through D), would it be a better representation to show these data as a percent of total cells rather than per image? There is a very large variability in some of these data, and perhaps an adjustment to the number of total cells might allow for reducing this across groups, and perhaps finding differences where p values currently outside the normally-accepted level of \"difference\" could be reduced to difference. IN addition, this would actually be a more valid way to assess the figures anyway.

Response: To be consistent with our prior study we have used cells per area as our unit of measurement for all stromal cell types. However, we agree that "per image" isn't as precise and have converted figures quantifying stromal cells to cells per mm2.

Comment 3: The authors could comment on the body mass of these dogs: is there any difference in obesity rates or other obvious BPH-related risk factors in some of the older animals that could play a role in collagen deposition and cell type shifts as the animals age? The group has a great resource of animals that could yield this information. If the numbers are too low currently to warrant further stratification, perhaps a comment on this would be warranted.

Response: We did not have sufficient numbers for stratification but have added this to the discussion as a future direction.

Reviewer \#2:

The work by Ruetten et al looks at the identification of stromal cells responsible for the production of procollagen 1A1 in dogs with lower urinary tract dysfunction related to prostate changes associated with aging. The authors used immunohistochemical analysis to identify the location of these cells. This study provides a framework for future studies when looking at changes in prostatic diseases in dogs. However, there are a few questions that require clarification.

Comment 1: Our current understanding of the human prostate anatomy is based on the classic work by McNeal (1968) who proposed four different prostatic zones based on their anatomic location and histological features. The presence of these four zones have been validated recently by others (Selman et al 2011, Samson 2012) and also using MRI technologies (Yacoub 2018). Please revised the statement "...that are organized into three zones" (lane 71) accordingly.

Response: This has been corrected to "four zones".

Comment 2: Please revise the following statement for accuracy: "We found that aging increases collagen fiber thickness and density in the capsule and peripheral regions intact dogs susceptible to prostatism". The conclusions of this reference suggest that older dogs have increased collagen fiber thickness and density compared to young male dogs. However, in this particular paper there was not any evidence that these changes in collagen were present in dogs with "prostatism". Dogs were euthanized for reasons other than prostatic disease. Unlike humans, typically no clinical signs of LUTS are present in dogs unless the BPH condition progress to hematuria, tenesmus, urethral discharge or stilted gait. Similarly, in prostate cancer signs and symptoms are also present later in the disease.

Response: This has been corrected for accuracy.

Comment 3: In figure 1 the data on epithelial cells is presented as a percentage over total number of cells, however from figure 2, number of cells/image. Given that each field is representative of the gland architecture, perhaps it will be more informative if the data is presented as percentage of total number of cells, also for consistency.

Response: To be consistent with our prior study we have used cells per area as our unit of measurement for all stromal cell types. However, we agree that "per image" isn't as precise and have converted figures quantifying stromal cells to cells per mm2.

Comment 4: Did the authors compared whether cell densities for each of these populations are different between the four regions? Looking at Figure 4 , it looks like there are more fibroblasts in the capsule and peripheral zone compared to the periurethral and urethral zones. Unfortunately, it is hard to determine because the y axis used are different between groups.

Response: Statistical comparisons were only made between or among images collected form the same microscope using the same imaging settings and magnification. And were only made for cell types in a single stain. However, we have made y-axis and units consistent across figures to enable visual comparisons between groups.

Comment 5: Figure 5 (panels E to H) will benefit with the use of colors instead of the shades of gray. Another alternative is to use a combination of white, gray and black.

Response: This figure now utilizes white, gray, and black.

Comment 6: The authors did a great job looking at epithelial and fibroblasts cell populations using a combination of markers to classify them (luminal/intermediate/basal and NE for epithelial cells and fibroblasts/myofibroblasts) and only use one marker for the hematolymphoid (?), perhaps one of the most well studied and diverse in terms of subpopulations. This study will be complete if the authors can provide some evidence of lymphoid and/or myeloid cell populations distribution across the dog prostate. Given that inflammatory processes are clearly involved in the promotion of collagen deposition (per the authors premise for looking at collagen in this study), determining whether macrophages or lymphocytes associate with areas of high collagen content or presence of specific fibroblasts population will give a much better picture on hematolymphoid cells in young vs old dogs.

Response: We chose stain combinations based on our immunohistochemical identification key for prostatic cell types in mouse in order to allow cross species comparisons. We agree that many subpopulations exist within our categories, not only in the hematolymphoid category but in other cell type classifications as well. We hope that this work is a starting point for researchers who can add on their own immunohistochemical stain combinations and classify further unique subpopulations as part of a partonomic ontology. We agree that studies assessing the inflammatory environment in which collagen changes are occurring in an important future direction but rather than adding more to this body of work we think this information would be better suited for a standalone manuscript where there is room to explore not only lymphoid vs myeloid but common immune cell types including B-cells, T-cells, neutrophils, macrophages, etc. and their known subtypes.

Comment 7: It is well known that larger breeds of dogs are at higher risk of developing prostate cancer. Did the authors compared whether changes in collagen deposition are different between different breeds?. Or if prostate size was associated with the composition/distribution of collagen?

Response: We did not have sufficient numbers for stratification but have added this to the discussion as a future direction

###### 

Submitted filename: Final Response to reviewers.docx

###### 

Click here for additional data file.

10.1371/journal.pone.0232564.r003
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Dear Dr. Chad M Vezina

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <http://www.editorialmanager.com/pone/>, click the \'Update My Information\' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible \-- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

Kind regards,

**Mohammad Saleem,  **

Academic Editor, PLOS ONE

**Dept. of Urology, Masonic Cancer Center, University of Minnesota**
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Dear Dr. Vezina:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.
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